Ace Report Cover
Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Reprints
Cite This
Reprints
Cite This
AceReport Image
Trauma
Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Verified
This report has been verified by one or more authors of the original publication.
Arthroscopy. 2014 Aug;30(8):987-96

Data from 14 Level I or Level II randomized controlled trials (N=4726) was gathered in this meta-analysis. The aim of this study was to assess the efficacy of low-molecular-weight heparin venous thromboprophylaxis versus placebo/no treatment in non-major orthopaedic patients with transient reduced mobility. Findings indicated significant risk reduction of thromboembolic events with prophylactic low-molecular-weight heparin compared to the absence of prophylaxis.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events. ACE Report. 2014;4(10):33. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report